Acrongenomics Inc. (OTCBB: AGNM) today announces that Dr. Evan Manolis is appointed Chairman of its Board of Directors effective immediately. Dr. Manolis has been a board member of Acrongenomics since 2006. He received his B.Sc.

Acrongenomics, Inc.

Acrongenomics Inc. (AGNM: OTCBB), today announces that it is fully committed to the joint collaboration contract in partnership with Molecular Vision.

Acrongenomics Inc., (OTCBB:AGNM) today announces that discussions with Molecular Vision on the remaining acquisition of Molecular Vision have ceased for the present time. Acrongenomics remains a significant shareholder in Molecular Vision, having recently acquired a 10.9% stake in the company.

Further to the company's announcement dated February 14th 2008 for the remaining acquisition of Molecular Vision, Ltd., Acrongenomics, Inc. (OTCBB:AGNM) today announces that the negotiations are still ongoing.